Winrevair, when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with PAH, trial data show.

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.

Columnist Jolie Lizana attended the Pulmonary Hypertension Association's (PHA) PHPN Symposium, which discussed PH research.

As a PH patient and transplant recipient, columnist Anna Jeter relies on her care team when it comes to vaccine recommendations.

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, in a ...

Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blindness ...

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Europe.

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people with PAH and PH-ILD.